Hyperfine
clinical proof twenty five peer reviewed publications to date and significant investment in studies in new clinical use cases | Hyperfine
Company
Deck Type
Sector
Industry
Deck date
September 2023
Slide
12 of 22
Similar slides by Hyperfine
See diffirences between slides (animation)
Investor Presentation
November 2023
clinical proof twenty five peer reviewed publications to date and significant investment in studies in new clinical use cases | Hyperfine
Related slides by other companies
Exscientia
Investor Presentation
August 2023
why are our clinical candidates different | Exscientia
BenevolentAI
Results
March 2024
| BenevolentAI
Exscientia
Investor Presentation
July 2023
why are our clinical candidates different | Exscientia
MindMed
Investor Presentation
June 2023
phase study results key phase study results support progression of results from phase progression of clinical trial demonstrate tolerability and support linear maintained across the tested doses and clinical effects align with potent regimen suitable regimen in withdrawal aligns with preclinical evidence offers potential to be a more frequencies engagement | MindMed
Other recent decks by Hyperfine
See all presentations (5 decks)
Investor Presentation
November 2023
Investor Presentation
November 2023
Investor Presentation
August 2023
SPAC
July 2021
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io